Long-term patency (9 1/4 years) and altherosclerosis of a polytetrafluoroethylene (Gortexx®) Coronary antery bypass graft

Clinical Cardiology

Volumn 21, Issue 1, 1998, Pages 60-62

  Vlay, Stephen C ^a   Malik, Amir Z ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Coronary artery bypass graft; Gortex ; Hyperlipedimia; Polytetrafluouroethylene

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MEVINOLIN; POLITEF; TRIACYLGLYCEROL; WARFARIN;

AGED; ANTICOAGULATION; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GRAFT PATENCY; HUMAN; HYPERCHOLESTEROLEMIA; POLITEF IMPLANT;

EID: 0031909631     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960210112     Document Type: Article

References (12)

1. Hartman AR, Vlay SC, Dervan JP, Lawson WE, Mannisi J, Anagnostopoulos CE: Emergency coronary revascularization using polytetrafluoroethylene conduits in a patient with cardiogenic shock. Clin Cardiol 1991;14:75-78
2. Murta M, Mestres CA, Igual A: Long-term patency of polytetrafluoroethylene vascular grafts in coronary artery surgery. Ann Thorac Surg 1985;39:86-87
3. McCullough JN, Abel RM, Rubenstein H: Polytetrafluoroethylene graft for spontaneous coronary artery dissection: 7 year follow-up. Ann Thorac Surg 1990;50:663-664
4. Hehrlein W, Schlepper M, Loskot F, Scheld HH, Walter P, Mulch J: The use of expanded polytetrafluoroethylene grafts for myocardial revascularization. J Cardiovasc Surg 1994;25:549-553
5. Molina JE, Carr M, Yarnoz MD: Coronary bypass with Gore-Tex graft. J Thorac Cardiovasc Surg 1978;75:769-771
6. Yokoyama Gharavi MA, Lee Y, Edmiston WA, Kay JH: Aorta-coronary artery revascularization with an expanded polytetrafluoroethylene vascular graft. J Thorac Cardiovasc Surg 1978;76: 552-555
7. Sapsford RN, Oakley GD, Talbot S: Early and late patency of expanded polytetrafluoroethylene vascular grafts in aorta-coronary bypass. J Thorac Cardiovasc Surg 1981;81:860-864
8. Sauvage LR, Schloemer R, Wood SJ, Logan G: Successful interposition synthetic graft between aorta and right coronary artery. J Thorac Cardiovasc Surg 1976;72:418-121
9. Tomizawa Y: Vascular protheses for aortocoronary artery bypass grafting: A review. Artificial Organs 1995;19:39-45
10. Scheld HH, Gorlach G, Moosdorf R, Loskot F, Hehrlein FW: PTFE grafts to the right coronary artery following endarterectomy. Herz 1997;12:237-240
11. Campeau L, Knatterud GL, Domanski M, Hunninghake DB, White CW, Geller NL, Rosenberg Y: The effect of aggressive lipid lowering of LDL cholesterol levels and low dose anticoagulation on obstructive changes in saphenous vein coronary artery bypass grafts. N Engl J Med 1997;336(3):153-162
12. Emery RW, Mills NL, Teijeira FJ, Arom KV, Baldwin P, Petersen RJ, Joyce LD, Grinnan GLB, Sussman MS, Copeland JG, Ochsner JL, Boyce SW, Nicoloff DM: North American experience with the Perma-Flow prosthetic coronary graft. Ann Thorac Surg 1996;62: 691-696